ABT

ABT Net Change in Cash

-$1.85BTTM · USD

Period ending:

ABT FY Net Change in CashUSD
ABT FY Net Change in Cash1989-12-31: -$377.30M1990-12-31: $20.40M1991-12-31: $26.40M1992-12-31: $56.10M1993-12-31: $184.10M1994-12-31: -$10.40M1995-12-31: -$9.08M1996-12-31: -$170.99M1997-12-31: $119.82M1998-12-31: $78.21M1999-12-31: $292.86M2000-12-31: $306.12M2001-12-31: -$256.84M2002-12-31: $47.07M2003-12-31: $290.67M2004-12-31: $230.50M2005-12-31: $1.67B2006-12-31: -$2.37B2007-12-31: $1.94B2008-12-31: $1.66B2009-12-31: $4.70B2010-12-31: -$5.16B2011-12-31: $3.16B2012-12-31: $3.99B2013-12-31: -$7.33B2014-12-31: $588.00M2015-12-31: $938.00M2016-12-31: $13.62B2017-12-31: -$9.21B2018-12-31: -$5.56B2019-12-31: $16.00M2020-12-31: $2.98B2021-12-31: $2.96B2022-12-31: $83.00M2023-12-31: -$2.99B2024-12-31: $720.00M2025-12-31: $906.00M$13.62B-$9.21B
1989-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ABT net change in cash history

Net period-over-period change in cash balance. The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 31, 2025.

Abbott Laboratories Net Change in Cash — Annual fiscal periods (USD)
Period endingNet Change in Cash (USD)
906,000,000
720,000,000
-2,986,000,000
83,000,000
2,961,000,000
2,978,000,000
16,000,000
-5,563,000,000
-9,213,000,000
13,619,000,000
938,000,000
588,000,000
-7,327,000,000
3,989,343,000
3,164,449,000
-5,160,968,000
4,697,317,000
1,655,638,000
1,935,192,000
-2,372,495,000
1,668,059,000
230,504,000
290,674,000
47,072,000
-256,840,000
306,121,000
292,859,000
78,206,000
119,815,000
-170,988,000
-9,075,000
-10,404,000
184,100,000
56,100,000
26,400,000
20,400,000
-377,300,000

Compare net change in cash

All ABT financial metrics · ABT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.